SOPHiA GENETICS SA·4

Jun 26, 4:03 PM ET

Verma Abhimanyu 4

4 · SOPHiA GENETICS SA · Filed Jun 26, 2026

Research Summary

AI-generated summary of this filing

Updated

SOPHiA GENETICS (SOPH) CTO Abhimanyu Verma Sells 6,944 Shares

What Happened

  • Abhimanyu Verma, Chief Technology Officer of SOPHiA GENETICS (SOPH), sold 6,944 shares on 2026-06-25 in open-market transactions. The weighted-average sale price was $5.51 per share, for aggregate proceeds of approximately $38,229. This was a sale (code S) and appears to be a routine disposal to satisfy tax withholding obligations from RSU vesting.

Key Details

  • Transaction date: 2026-06-25; Form 4 filed 2026-06-26 (timely).
  • Price: weighted average $5.51; individual trade prices ranged $5.31–$5.69. (Reporting person can provide exact breakdown on request — see footnote F2.)
  • Reason: Sold to satisfy tax withholding on vested restricted stock units under a pre-established Rule 10b5‑1(c) plan (footnote F1). The sale was not a discretionary trade.
  • Shares owned after the transaction: not disclosed in this filing.

Context

  • Sales executed solely to cover tax obligations (and done under a 10b5‑1 plan) are common and generally viewed as routine rather than a clear signal about the insider’s view of the company. Purchases tend to carry more weight for signaling, while tax-withholding sales typically do not.

Insider Transaction Report

Form 4
Period: 2026-06-25
Verma Abhimanyu
Chief Technology Officer
Transactions
  • Sale

    Ordinary Shares

    [F1][F2]
    2026-06-25$5.51/sh6,944$38,229197,456 total
Footnotes (2)
  • [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.31 to $5.69, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Abhimanyu Verma|2026-06-26

Documents

1 file
  • 4
    wk-form4_1782504189.xmlPrimary

    FORM 4